Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Embryonic tumours of the central nervous system.

Literature DB >> 15960935

Embryonic tumours of the central nervous system.

Aurora Navajas Gutiérrez¹, Ana Fernández-Teijeiro Alvarez.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 15960935 DOI： 10.1007/bf02712821

Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.405

× No keyword cloud information.

38 in total

1. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors: D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal: Eur J Cancer Date: 1990-04 Impact factor: 9.162

2. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Authors: S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern
Journal: J Clin Oncol Date: 2001-04-15 Impact factor: 44.544

3. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

Authors: R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar
Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544

Review 4. High-dose chemotherapy in childhood brain tumours.

Authors: C Kalifa; D Valteau; B Pizer; G Vassal; J Grill; O Hartmann
Journal: Childs Nerv Syst Date: 1999-10 Impact factor: 1.475

Review 5. Modern treatment strategies in medulloblastoma.

Authors: J Kühl
Journal: Childs Nerv Syst Date: 1998 Jan-Feb Impact factor: 1.475

6. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors: P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544

Review 1. Evidence in medulloblastomas.

Authors: A Navajas; J Giralt
Journal: Clin Transl Oncol Date: 2010-04 Impact factor: 3.405

1 in total

Embryonic tumours of the central nervous system.

1. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

2. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

3. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

Review 4. High-dose chemotherapy in childhood brain tumours.

Review 5. Modern treatment strategies in medulloblastoma.

6. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

7. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

8. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.

Review 9. Anaplasia and grading in medulloblastomas.

10. Clinical and molecular stratification of disease risk in medulloblastoma.

Review 1. Evidence in medulloblastomas.